TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16634072

Group type: EXPERIMENTAL
Intervention: Non-surgical treatment with Er:YAG laser (12.7 J/cm2)
Number of subjects: 12
Study: 15292850

Group type: EXPERIMENTAL
Intervention: Rehabilitation group (160 mg/d oral testosterone undecanoate for men, 80 mg/d for women, 563 kcal/d oral dietary supplements, exercise on ergometric bicycle 3 to 5 times a week)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (7 home visits for education)
Number of subjects: 200
Study: 11736729

Group type: EXPERIMENTAL
Intervention: ranitidine bismuth citrate, furazolidone, amoxicillin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ranitidine bismuth citrate, furazolidone, tetracycline
Number of subjects: 120
Study: 9246988

Group type: EXPERIMENTAL
Intervention: External fixation a.m. Hoffmann
Number of subjects: 60

Group type: COMPARATOR
Intervention: Percutaneous Kirschner wire pinning combined with immobilization in a plaster cast
Number of subjects: 60
Study: 8000793

Group type: EXPERIMENTAL
Intervention: Simultaneous measurements of free, oligomer‐bound and protein‐bound sialic acids in blood serum, saliva, and tissue homogenates
Number of subjects: 0
Study: 3712426

Group type: EXPERIMENTAL
Intervention: Behavior modification clinics followed by an intensive media campaign
Number of subjects: 0

Group type: COMPARATOR
Intervention: Behavior modification clinics alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Packet of smoking cessation material in the mail
Number of subjects: 0
Study: 30540552

Group type: EXPERIMENTAL
Intervention: Coinfection of 11 generalist viruses
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Generalized regression models
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Network analyses of coinfection
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Ecological interactions
Number of subjects: 47
Study: 29523206

Group type: EXPERIMENTAL
Intervention: School-based humanistic counselling (SBHC) delivered in up to 10 weekly sessions by a qualified counsellor.
Number of subjects: 306

Group type: COMPARATOR
Intervention: Pastoral Care as Usual (PCAU)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: SBHC
Number of subjects: 306
Study: 26108438

Group type: EXPERIMENTAL
Intervention: Resistance exercise training for 16 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (diabetes without neuropathy and healthy controls)
Number of subjects: 43
Study: 25493153

Group type: EXPERIMENTAL
Intervention: Online ACLS simulator access (n=29)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (n=36)
Number of subjects: 65
Study: 23672102

Group type: EXPERIMENTAL
Intervention: Interval training program (n=140) for 8 weeks, 45-60 minutes at 60-79% HR reserve
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control group (n=105) remained sedentary
Number of subjects: 245
Study: 20173082

Group type: EXPERIMENTAL
Intervention: Telcagepant single oral doses (up to 1200 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telcagepant multiple oral doses (400 mg twice daily)
Number of subjects: 0
Study: 18005835

Group type: EXPERIMENTAL
Intervention: Cervical headgear combined with full fixed appliances
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pendulum appliance followed by full fixed appliances
Number of subjects: 60
Study: 16027585

Group type: EXPERIMENTAL
Intervention: Firearm safety training using scripted discussion, psychomotor exercise, and role-playing exercise
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 57
Study: 12665049

Group type: EXPERIMENTAL
Intervention: Two 80‐mg tablets twice daily
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Two 80‐mg tablets three times daily
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 100
Study: 9808910

Group type: EXPERIMENTAL
Intervention: Postmenopausal women
Number of subjects: 82

Group type: COMPARATOR
Intervention: Pre-menopausal women (control)
Number of subjects: 82
Study: 7631952

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine with fentanyl (group B-F)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine with sufentanil (group B-S)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Epidural bupivacaine alone (group B)
Number of subjects: 36
Study: 2654214

Group type: EXPERIMENTAL
Intervention: Twice-daily (nonoccluded) superpotent topical steroids for 2 weeks
Number of subjects: 118
Study: 962352

Group type: EXPERIMENTAL
Intervention: Topical glucocorticosteroids
Number of subjects: 10

Group type: COMPARATOR
Intervention: Matched control group (no steroid treatment)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Topical glucocorticosteroids (retesting after one month)
Number of subjects: 10
Study: 30104408

Group type: EXPERIMENTAL
Intervention: Comparative risk messages (CR messages)
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Comparative risk messages with more negative antismoking elements (CR- messages)
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Control message
Number of subjects: 1400
Study: 28498275

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (2-week duration)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Matched placebo (2-week duration)
Number of subjects: 105
Study: 25445851

Group type: EXPERIMENTAL
Intervention: Early voice therapy (within 4 weeks from injury)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Intermediate voice therapy (from 4 to 8 weeks after injury)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Delayed voice therapy (at least 8 weeks after injury)
Number of subjects: 171
Study: 23368699

Group type: EXPERIMENTAL
Intervention: Case-based intervention using email to augment in-person seminars
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no case-based intervention)
Number of subjects: 71
Study: 21632552

Group type: EXPERIMENTAL
Intervention: sTNF-R1 (quartile 4 vs. quartile 1)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: sCD27
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: sTNF-R1 (for cases diagnosed longer than 6 years post-collection)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: sCD27 (for cases diagnosed longer than 6 years post-collection)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: IL-10
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: TNF-α
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: sTNF-R2
Number of subjects: 297
Study: 19368922

Group type: EXPERIMENTAL
Intervention: Folic acid-iron
Number of subjects: 3986

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients
Number of subjects: 3986

Group type: EXPERIMENTAL
Intervention: Folic acid-iron, folic acid-iron-zinc, and multiple micronutrients
Number of subjects: 3986
Study: 17299383

Group type: EXPERIMENTAL
Intervention: Olibra yoghurt
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo yoghurt
Number of subjects: 50
Study: 15497550

Group type: EXPERIMENTAL
Intervention: High-resolution kinetic mapping method
Number of subjects: 24

Group type: COMPARATOR
Intervention: Static mapping
Number of subjects: 24
Study: 11323139

Group type: EXPERIMENTAL
Intervention: Painful heat (540 mJ punctate laser stimuli, 5 mm diameter)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Non-painful touch (16 mN von Frey probe, 1.1 mm diameter)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mechanically-induced pain (256 mN punctate probe, 200 microm diameter)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sequential spatial discrimination for touch
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Finger tip localization
Number of subjects: 12
Study: 9783189

Group type: EXPERIMENTAL
Intervention: Short-term intravesical instillation of pirarubicin (THP) for daily for 7 consecutive days from the day of TUR-BT and subsequently once a week for 10 weeks (17 times in total)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Short-term intravesical instillation of pirarubicin (THP) once every two weeks for 6 months (12 times) starting 2 weeks after TUR and subsequently once a month until one year had passed after surgery (6 times, 18 times in total)
Number of subjects: 69
Study: 7870558

Group type: EXPERIMENTAL
Intervention: Visual distractors (computer-generated dynamic graphic images) during skilled proofreading task
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Visual distractors (computer-generated dynamic graphic images) during unskilled proofreading task
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Visual distractors (computer-generated dynamic graphic images) during listening comprehension task
Number of subjects: 32
Study: 3127600

Group type: EXPERIMENTAL
Intervention: Keyhole-limpet hemocyanin (1 mg intracutaneously for immunization, followed by 10 mg monthly bladder instillations)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Keyhole-limpet hemocyanin (10 mg monthly bladder instillations)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Mitomycin C (20 mg monthly)
Number of subjects: 44
Study: 30651321

Group type: EXPERIMENTAL
Intervention: TTP399 (800 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28282300

Group type: EXPERIMENTAL
Intervention: Tenofovir Alafenamide (TAF)
Number of subjects: 1733

Group type: COMPARATOR
Intervention: Tenofovir Disoproxil Fumarate (TDF)
Number of subjects: 1733
Study: 25848134

Group type: EXPERIMENTAL
Intervention: rhPDGF‐BB/β‐TCP‐collagen
Number of subjects: 75

Group type: COMPARATOR
Intervention: autograft
Number of subjects: 75
Study: 23412171

Group type: EXPERIMENTAL
Intervention: Arthroscopic microfracture with PRP (24 patients)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Arthroscopic microfracture only (25 patients)
Number of subjects: 49
Study: 21134693

Group type: EXPERIMENTAL
Intervention: Lenograstim
Number of subjects: 0

Group type: COMPARATOR
Intervention: Filgrastim
Number of subjects: 0
Study: 19225876

Group type: EXPERIMENTAL
Intervention: E(2) pre‐treatment group (n=109)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (n=111)
Number of subjects: 220
Study: 17129185

Group type: EXPERIMENTAL
Intervention: Patients with striatal lesions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients with frontal lobe lesions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline nonswitch trials
Number of subjects: 0
Study: 15192923

Group type: EXPERIMENTAL
Intervention: Calculated insulin dose (CALC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional insulin dose (C)
Number of subjects: 60
Study: 11275919

Group type: EXPERIMENTAL
Intervention: Long-acting antianginal medications (long-acting diltiazem +/− nitroglycerin patches +/− atenolol)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Optimal adjustment of usual antianginal medications
Number of subjects: 100
Study: 9294499

Group type: EXPERIMENTAL
Intervention: Capnography
Number of subjects: 55

Group type: COMPARATOR
Intervention: Auscultation of breath sounds
Number of subjects: 55
Study: 8438711

Group type: EXPERIMENTAL
Intervention: Physician-delivered smoking interventions
Number of subjects: 1261
Study: 3525343

Group type: EXPERIMENTAL
Intervention: Melphalan
Number of subjects: 185

Group type: COMPARATOR
Intervention: Melphalan plus C. parvum
Number of subjects: 185
Study: 31152310

Group type: EXPERIMENTAL
Intervention: Cryopreserved umbilical cord (UC) allograft
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (no UC)
Number of subjects: 200
Study: 30144421

Group type: EXPERIMENTAL
Intervention: Thin bronchoscope and radial endobronchial ultrasound (TB-EBUS)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Standard bronchoscopy and fluoroscopy (SB-F)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Standard bronchoscopy and fluoroscopy (SB-F) with crossover to TB-EBUS
Number of subjects: 197
Study: 27166077

Group type: COMPARATOR
Intervention: Psyllium 3.4 g
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psyllium 6.8 g
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psyllium 10.2 g
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psyllium 6.8 g (Study 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 0
Study: 23895084

Group type: EXPERIMENTAL
Intervention: Trauma‐focused cognitive behavioral therapy (TF‐CBT)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Therapy as usual (TAU)
Number of subjects: 156
Study: 22745116

Group type: EXPERIMENTAL
Intervention: Anterior catheter tip placement
Number of subjects: 32

Group type: COMPARATOR
Intervention: Posterior catheter tip placement
Number of subjects: 32
Study: 20557327

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA) administered subcutaneously every 2 weeks, titrated to maintain a target Hb level of 14.0±1.0 g/dL
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA)
Number of subjects: 475

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 475
Study: 18657736

Group type: EXPERIMENTAL
Intervention: Surgical reinsertion of the medial patellofemoral ligament (MPFL) to the adductor tubercle
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conservative treatment (use of a brace with 0 degrees to 20 degrees motion for the first 2 weeks after dislocation)
Number of subjects: 80
Study: 15877291

Group type: EXPERIMENTAL
Intervention: 1.2 g/min of glucose (GLU)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1.2 g/min of sucrose (SUC)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.6 g/min of glucose + 0.6 g/min of sucrose (M-GLU+SUC)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1.2 g/min of glucose + 1.2 g/min of sucrose (H-GLU+SUC)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Water (WAT)
Number of subjects: 8
Study: 12689354

Group type: EXPERIMENTAL
Intervention: Vocalists
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control
Number of subjects: 22
Study: 12552030

Group type: EXPERIMENTAL
Intervention: Topiramate 500 mg/d
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/d
Number of subjects: 252

Group type: COMPARATOR
Intervention: Topiramate 50 mg/d
Number of subjects: 252
Study: 9802630

Group type: EXPERIMENTAL
Intervention: Benzathine penicillin G diluted with lidocaine hydrochloride 1%
Number of subjects: 18

Group type: COMPARATOR
Intervention: Benzathine penicillin G diluted with sterile water
Number of subjects: 18
Study: 7706451

Group type: EXPERIMENTAL
Intervention: Table wine (ethanol content 71 g)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Water
Number of subjects: 14
Study: 2568808

Group type: EXPERIMENTAL
Intervention: Iotrolan
Number of subjects: 60

Group type: COMPARATOR
Intervention: Iopromide
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 60
Study: 1066333

Group type: EXPERIMENTAL
Intervention: Xylitol (X)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Fructose (F)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sucrose (S)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Xylitol (X) in chewing gum
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sucrose (S) in chewing gum
Number of subjects: 102
Study: 29506422

Group type: EXPERIMENTAL
Intervention: DEFB1 c.*87-A allele
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: GCGA haplotype
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: ACGG haplotype
Number of subjects: 101
Study: 28928186

Group type: EXPERIMENTAL
Intervention: rhTNK-tPA (16 mg intravenous bolus)
Number of subjects: 6200

Group type: COMPARATOR
Intervention: Alteplase (rt-PA) (8 mg intravenous bolus followed by 42 mg infusion over 90 mins)
Number of subjects: 6200
Study: 26341762

Group type: EXPERIMENTAL
Intervention: mini-laparoscopic donor nephrectomy (mLDN)
Number of subjects: 100

Group type: COMPARATOR
Intervention: standard laparoscopic donor nephrectomy (sLDN)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (mLDN and sLDN)
Number of subjects: 100
Study: 23555624

Group type: EXPERIMENTAL
Intervention: internet-delivered Cognitive Behaviour Therapy (iCBT)
Number of subjects: 562

Group type: COMPARATOR
Intervention: internet-delivered attention control health information package (HealthWatch)
Number of subjects: 562
Study: 21802850

Group type: EXPERIMENTAL
Intervention: Massage Therapy (MT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Social attention control condition
Number of subjects: 72
Study: 19367435

Group type: EXPERIMENTAL
Intervention: 0.25% glyceryl trinitrate ointment and anal cryothermal dilators
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.4% glyceryl trinitrate ointment alone
Number of subjects: 60
Study: 16957424

Group type: EXPERIMENTAL
Intervention: Telmisartan-HCTZ (80/25 mg)
Number of subjects: 1066

Group type: EXPERIMENTAL
Intervention: Valsartan-HCTZ (160/25 mg)
Number of subjects: 1066

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1066
Study: 15042133

Group type: EXPERIMENTAL
Intervention: Transitional food process (TFP) scale
Number of subjects: 6747

Group type: EXPERIMENTAL
Intervention: Eating ability index (EAI) calculated as (number of accepted foods/total number of foods) x 100
Number of subjects: 6747

Group type: EXPERIMENTAL
Intervention: Breast feeding, bottle feeding with chewing-type nipples, and family table food preparation
Number of subjects: 6747

Group type: EXPERIMENTAL
Intervention: Information from books or magazines
Number of subjects: 6747
Study: 11140546

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate 3.75 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate 7.5 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study: 9074532

Group type: EXPERIMENTAL
Intervention: 99mTc‐tetrofosmin
Number of subjects: 24

Group type: COMPARATOR
Intervention: 99mTc‐sestamibi
Number of subjects: 24
Study: 8362998

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention combining refusal skills training, contingency management, and telephone boosters
Number of subjects: 2668

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2668

Group type: EXPERIMENTAL
Intervention: Intervention vs Control
Number of subjects: 2668
Study: 31583611

Group type: EXPERIMENTAL
Intervention: Finerenone 20 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Finerenone 10 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 0
Study: 29166779

Group type: EXPERIMENTAL
Intervention: PA intervention (free PA classes, 6 times per week)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Attention control (cancer prevention workshops)
Number of subjects: 319
Study: 27126144

Group type: EXPERIMENTAL
Intervention: Five-question protocol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Single open-ended question
Number of subjects: 48
Study: 24738111

Group type: EXPERIMENTAL
Intervention: Conventional antipsychotics (perphenazine, sulpiride, chlorpromazine)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics (clozapine, quetiapine, aripiprazole)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 163
Study: 22853887

Group type: EXPERIMENTAL
Intervention: Hippotherapy intervention program (10-week duration)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 19
Study: 20457363

Group type: EXPERIMENTAL
Intervention: AcrySof ReSTOR SN60D3 (+4.00 D add)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: AcrySof ReSTOR SN6AD3 (+4.00 D add)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acri.LISA 366D (+3.75 D add)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: AcrySof ReSTOR SN6AD1 (+3.00 D add)
Number of subjects: 40
Study: 17942205

Group type: EXPERIMENTAL
Intervention: Formaldehyde exposure at 0.5 ppm with peaks of 1.0 ppm
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Formaldehyde exposure at 0.3 ppm
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Formaldehyde exposure at 0.5 ppm plus peaks of 1.0 ppm
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Formaldehyde exposure at 0.3 and 0.5 ppm with co-exposure to ethyl acetate (EA)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ethyl acetate (EA) exposure only
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Personality factor 'anxious'
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Formaldehyde exposure at 0.5 ppm with peaks of 1 ppm
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Formaldehyde exposure at 0.3 ppm with peaks of 0.6 ppm
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Post-exposure symptom scores
Number of subjects: 21
Study: 15880077

Group type: EXPERIMENTAL
Intervention: Laparoscopic living-donor nephrectomy (L-LDN)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Open living-donor nephrectomy (O-LDN)
Number of subjects: 122
Study: 12919638

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy (ES)
Number of subjects: 166

Group type: COMPARATOR
Intervention: No specific treatment (control)
Number of subjects: 166
Study: 10546391

Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemohyperthermia (IPCH) with an open procedure and upwards traction of the skin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intraperitoneal chemotherapy (IPIC) lasting four days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Procedures with closure of the abdomen
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intra-abdominal complications
Number of subjects: 32

Group type: COMPARATOR
Intervention: Overall complications
Number of subjects: 32
Study: 8756737

Group type: EXPERIMENTAL
Intervention: Hemodialysis therapy for over 50 months
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Hemodialysis therapy for less than 100 months
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Hemodialysis therapy for over 100 months
Number of subjects: 56

Group type: COMPARATOR
Intervention: Chronic renal insufficiency (compared to healthy controls)
Number of subjects: 56
Study: 1861510

Group type: EXPERIMENTAL
Intervention: Wei Yang An (easing peptic-ulcer capsule)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 0
Study: 6869735

Group type: EXPERIMENTAL
Intervention: Thiopentone 4.5 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Midazolam 0.3 mg/kg
Number of subjects: 20
Study: 30262599

Group type: EXPERIMENTAL
Intervention: Prediagnostic serum levels of 8-HETE (tertile 3 vs. 1)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Prediagnostic serum levels of 12,13-DHOME
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Prediagnostic serum levels of 13-HODE
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Prediagnostic serum levels of 9-HODE
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Prediagnostic serum levels of 9,12,13-THOME
Number of subjects: 313